Terminated OBSERVATIONAL NCT00837668

Stromal Gene Expression During Pulmonary Sarcoidosis

Sponsor: Ohio State University

Updated 11 times since 2017 Last updated: Jun 12, 2017 Started: Apr 30, 2005 Primary completion: Feb 29, 2012 Completion: Feb 29, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Interim analysis

Other terminated trials from Ohio State University

See all terminations from Ohio State University

Listed as NCT00837668, this observational or N/A phase trial focuses on Sarcoidosis and remains terminated or withdrawn. Sponsored by Ohio State University, it has been updated 11 times since 2005, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Dec 2021 — Jul 2024 [monthly]

Terminated
Jan 2021 — Dec 2021 [monthly]

Terminated
Nov 2020 — Jan 2021 [monthly]

Terminated

▶ Show 6 earlier versions

Jun 2018 — Nov 2020 [monthly]

Terminated
May 2018 — Jun 2018 [monthly]

Terminated
Apr 2018 — May 2018 [monthly]

Terminated

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Terminated NA
Jul 2017 — Aug 2017 [monthly]

Terminated NA

Status: Suspended → Terminated
Jan 2017 — Jul 2017 [monthly]

Suspended NA

First recorded

Apr 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ohio State University

Data source: Ohio State University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Columbus, United States